Clinical Trials in Salt Lake City

Showing 8401-8420 of 12,670 trials

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

NCT02537574

This study will evaluate the safety, effectiveness and tolerance of low doses of oral naltrexone along with buprenorphine to treat opioid use disorder prior to the first injection of VIVITROL.

Opioid Use Disorder

Alkermes, Inc.380 participantsStarted Aug 2015

Oceanside, California, United States • Orange, California, United States • Lauderhill, Florida, United States +17 more locations

COMPLETEDPhase 3< 1 mile

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

NCT00986154

Evaluation of heparin/edoxaban tosylate (DU176b) versus heparin/warfarin in preventing recurrence of blood clots in patients with acute symptomatic deep-vein blood clots in the legs and/or blood clots in the lungs.

Venous ThromboembolismDeep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+2 more

Daiichi Sankyo8,292 participantsStarted Oct 2009

Mobile, Alabama, United States • Montgomery, Alabama, United States • Phoenix, Arizona, United States +451 more locations

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study).

Find Trials by Condition in Salt Lake City

Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Heart Function in People Receiving an LVAD

Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy

Long-term Follow-up Study of Subjects Who Completed Clinical Studies 755.1100_FA, 810.1100_FA, or 1064.1100_FA

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Septic Shock

A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c

A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus Low Molecular Weight (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis

Inflammation and the Host Response to Injury (Trauma)

Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data

Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument

A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus

Validation of Non-Invasive Intracranial Pressure (ICP) Monitoring Device

Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors

An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)